SOURCE: Ivera Medical Corporation

Ivera Medical Corporation

October 08, 2013 05:00 ET

Ivera Medical Announces FSS Award

Made in the USA Curos® Disinfecting Port Protectors Now Available to All Veterans Affairs and Department of Defense Hospitals

SAN DIEGO, CA--(Marketwired - Oct 8, 2013) - Ivera Medical Corporation, a leading medical device innovator, announced that it has received a Veterans Administration (VA) Federal Supply Schedule contract for its innovative disinfecting caps for I.V. needleless connectors. Delegated authority by the General Services Administration, the Federal Supply Schedule (FSS) program supports the healthcare acquisition needs of the VA, Department of Defense (DoD), and other government agencies, managing programs for medical equipment, supply, pharmaceutical, and service contracts.

Ivera's innovative line of passive disinfection devices will assist hundreds of VA Hospitals nationwide in establishing more effective intravenous (IV) valve disinfection. Importantly, Ivera products are all manufactured in the USA.

The Curos® line of passive disinfection devices disinfect IV connectors, killing the organisms1 associated with patient bloodstream infections2 and eliminating the technique variation found in manual disinfection procedures. With two disinfecting port protector options -- Curos Strips and individual Curos -- nurses can conveniently comply with valve disinfection protocols by simply peeling the foil seal from the distinctive green cap and twisting Curos onto the top of any luer-activated IV access port. Inside Curos, a 70% isopropyl alcohol (IPA) saturated sponge-like foam bathes the surface of the venous access device to provide consistent and reliable disinfection of the port surface in 3 minutes. Once in place, Curos maintains a clean port for up to 7 days, if not removed. 

By purchasing from FSS approved vendors, VA and DoD Hospitals are assured that product pricing has been evaluated and approved as fair and reasonable and benefit from reduced administrative time for procurement.

"Ivera Medical is very pleased to receive this contract. We are proud to be made in the USA and to be selected to partner with federally-operated hospitals in an effort to reduce bloodstream infections and contaminated blood cultures and, in doing so, reduce overall healthcare costs," said Bob Rogers, Ivera Medical CEO.

About Ivera Medical
Ivera Medical Corporation, a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing and sale of products that help healthcare providers reduce facility-acquired patient infections. Curos, manufactured in Carlsbad, CA, is the first disinfecting cap to be marketed in the U.S. and has received FDA's 510(k) market clearance. For more information about Curos and Ivera Medical, visit the website at www.curos.com

References

1. Wenzel et al. The Impact of Hospital-Acquired Bloodstream Infections Emerging Infectious Disease • 2001 Vol 7, No 2. 174-177.

2. The effectiveness of Curos protectors were tested in vitro and was found to have > 4 log reduction against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Pseudomonas aeruginosa, Candida glabrata, and Candida albicans.